DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2h3cwq/mild_cognitive) has announced the addition of the "Mild Cognitive Impairment - Pipeline Review, H2 2013" report to their offering. 'Mild Cognitive Impairment - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline....
More...
